期刊文献+

EPBD术后并发急性胰腺炎的危险因素及预防的研究进展 被引量:3

Research Development in Risk Factors and Prevention for Acute Pancreatitis Following Endoscopic Papillary Balloon Dilation
暂未订购
导出
摘要 十二指肠乳头气囊扩张术(EPBD)是内镜下逆行性胰胆管造影的一种治疗手段,EPBD术后胰腺炎是常见且严重的并发症之一。目前研究发现,EPBD操作相关因素、病例选择相关因素、多次乳头插管及导丝多次插入胰管、多次胰管显影与操作者的经验不足是EPBD术后并发胰腺炎的常见危险因素。关于预防术后胰腺炎的药物研究已广泛开展,临床研究取得一定的进展。在内镜技术方面,改进操作技术,放置胰管支架和胆管引流技术,能有效地预防EPBD术后胰腺炎的发生。 Endoscopic papillary balloon dilation( EPBD) is one of treatment methods of endoscopic retrograde cholangio-pancreatography( ERCP) . Pancreatitis is one of common and severe complications secondary to EPBD. At present,it has been found that relevant factors for operation of EPBD,relevant factors for selection of procedure,repeated cannulation in papillary and insertion into pancreatic duct,multiple radiography of pancreatic duct,and insufficient experience of operators,are the common risk factors for acute pancreatitis following EPBD. Medical study on the prevention of pancreatitis after EPBD has been carried out extensively and has made certain progress. For endoscopic technology,the improvement of operative technique,placement of pancreatic duct stent,and drainage of bile duct,can prevent the pancreatitis after EPBD effectively.
作者 李恒 杜国平
出处 《医学综述》 2010年第21期3275-3277,共3页 Medical Recapitulate
关键词 十二指肠乳头气囊扩张术 急性胰腺炎 危险因素 预防 Endoscopic papillary balloon dilation Acute pancreatitis Risk factors Prevention
  • 相关文献

参考文献5

二级参考文献14

  • 1黄鹤,贾柳萍,谢春生,古雨平,王海霞.鼻胆管引流预防ERCP术后急性胰腺炎及高淀粉酶血症36例[J].南通大学学报(医学版),2005,25(2):109-110. 被引量:3
  • 2Cotton PB, Lehman G, Vennes J, et al. Endoscopic sphincterrotomy colaplications and their management: an attempt at consensus. Gastrointest Endosc, 1991,37: 383~ 393.
  • 3Suzuki H, Kobayashi H, Tannaka Y, et al. Structure and function analysis of urinarytrypsin inhibitor(UT 1 ) :identification of binding domains and signaling property of UTI by analysis of truncated proteins. Biochem Biophys Acta, 2001,1547: 26~ 36.
  • 4Gottlieb K,Sherman S. ERCP and endoscopic biliary sphincterotomy-induced pancreatitis. Gastrointest. Clin N Am,1998,8:87-114.
  • 5Testoni PA. Preventing post-ERCP pancreatitis: where are we? JOP,2003 ,4(1):22-32.
  • 6Freeman ML,DiSario JA,Nelson DB,et al.Risk factors for post-ERCP pancreatitis: a prospective, multicenter study . Gastrointest Endosc,2001,54:425-434.
  • 7Rabenstein T,Schneider HT,Nicklas M,et al.Impact of skill and experience of the endoscopist on the outcome of endoscopic sphincterotomy techniques. Gastrointest Endosc, 1999,50:628-636.
  • 8Karalis K,Mastorakos G,Chrousos GP,et al.Somatostatin analogues suppress the inflammatory reaction in vivo.J Clin Invest,1994,93:2000-2006.
  • 9Baxter JN,Jenkins SA,Day DW,et al.Effects of somatostatin and a long-acting somatostatin analogue on the prevention and treatment of experimentally induced acute pancreatitis in the rat.Br J Surg,1985,72:382-385.
  • 10李兆申,许国铭,孙振兴,邹晓平,金震东,谢苏庆.小剂量生长抑素预防ERCP术后高淀粉酶血症及胰腺炎的临床研究[J].第二军医大学学报,1997,18(5):426-427. 被引量:33

共引文献12

同被引文献20

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部